tetano
Editor, Senior Moderator
Nat Commun
. 2023 Aug 19;14(1):5055.
doi: 10.1038/s41467-023-40750-8. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Margaret L Lind[SUP] 1 [/SUP], Murilo Dorion[SUP] 2 [/SUP], Amy J Houde[SUP] 3 [/SUP], Mary Lansing[SUP] 3 [/SUP], Sarah Lapidus[SUP] 2 [/SUP], Russell Thomas[SUP] 2 [/SUP], Inci Yildirim[SUP] 2 4 [/SUP], Saad B Omer[SUP] 2 5 6 [/SUP], Wade L Schulz[SUP] 7 8 [/SUP], Jason R Andrews[SUP] 9 [/SUP], Matt D T Hitchings[SUP] 10 [/SUP], Byron S Kennedy[SUP] 3 [/SUP], Robert P Richeson[SUP] 3 [/SUP], Derek A T Cummings[SUP] #[/SUP][SUP] 11 12 [/SUP], Albert I Ko[SUP] #[/SUP][SUP] 13 14 [/SUP]
Affiliations
Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent ("leaky") protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25-0.54]; 0.57 [0.42-0.78]; 0.24 [0.15-0.39]; respectively) and with cellblock exposures (0.61 [0.49-0.75]; 0.69 [0.58-0.83]; 0.41 [0.31-0.55]; respectively) but not with cell exposures (0.89 [0.58-1.35]; 0.96 [0.64-1.46]; 0.80 [0.46-1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings.
. 2023 Aug 19;14(1):5055.
doi: 10.1038/s41467-023-40750-8. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
Margaret L Lind[SUP] 1 [/SUP], Murilo Dorion[SUP] 2 [/SUP], Amy J Houde[SUP] 3 [/SUP], Mary Lansing[SUP] 3 [/SUP], Sarah Lapidus[SUP] 2 [/SUP], Russell Thomas[SUP] 2 [/SUP], Inci Yildirim[SUP] 2 4 [/SUP], Saad B Omer[SUP] 2 5 6 [/SUP], Wade L Schulz[SUP] 7 8 [/SUP], Jason R Andrews[SUP] 9 [/SUP], Matt D T Hitchings[SUP] 10 [/SUP], Byron S Kennedy[SUP] 3 [/SUP], Robert P Richeson[SUP] 3 [/SUP], Derek A T Cummings[SUP] #[/SUP][SUP] 11 12 [/SUP], Albert I Ko[SUP] #[/SUP][SUP] 13 14 [/SUP]
Affiliations
- PMID: 37598213
- PMCID: PMC10439918
- DOI: 10.1038/s41467-023-40750-8
Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent ("leaky") protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25-0.54]; 0.57 [0.42-0.78]; 0.24 [0.15-0.39]; respectively) and with cellblock exposures (0.61 [0.49-0.75]; 0.69 [0.58-0.83]; 0.41 [0.31-0.55]; respectively) but not with cell exposures (0.89 [0.58-1.35]; 0.96 [0.64-1.46]; 0.80 [0.46-1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings.